top of page
Aducanumab: Panacea or Risk for Adults with Down Syndrome
Conference presentation
Virtual presentation on intellectual disability and possible application of aducanumab to
the ACCSES organization on August 5, 2021
bottom of page
Conference presentation
Virtual presentation on intellectual disability and possible application of aducanumab to
the ACCSES organization on August 5, 2021